IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $513,000 | -58.8% | 9,939 | -66.8% | 0.22% | -40.1% |
| Q2 2018 | $1,246,000 | -1.3% | 29,898 | +4.3% | 0.36% | +5.9% |
| Q1 2018 | $1,263,000 | -0.5% | 28,662 | +13.6% | 0.34% | -26.9% |
| Q4 2017 | $1,269,000 | +2.7% | 25,228 | +3.5% | 0.46% | +17.8% |
| Q3 2017 | $1,236,000 | -4.3% | 24,375 | -4.0% | 0.39% | +5.3% |
| Q2 2017 | $1,291,000 | +63.4% | 25,388 | +29.2% | 0.37% | +30.3% |
| Q1 2017 | $790,000 | +278.0% | 19,645 | +280.3% | 0.29% | -44.2% |
| Q1 2016 | $209,000 | – | 5,165 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |